ACOG
Alpha Cognition Inc.Company Information
- Company Name
- Alpha Cognition Inc.
- CIK
- CIK0001655923
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- ACOG: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- ACOG
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-09-25
- Last sale
- 2025-08-18
- Shares purchased (TTM)
- 698,409
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 10,427,411
- Shares outstanding
- 21,774,104
- Ownership
- 47.89%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 10.31%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Related Party | - | - | - | - | - | - | 1 | 1 | 0 | ||||||
Assets | |||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 41 | 54 | 66 | 35 | 39 | 46 | 49 | 4 | 1 | ||||||
| Restricted Cash Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Current | 5 | 4 | 4 | 3 | 2 | 0 | - | - | - | ||||||
Assets Current | |||||||||||||||
| Assets Current | 58 | 69 | 79 | 46 | 45 | 48 | 50 | 5 | 2 | ||||||
| Inventory Net | 6 | 6 | 5 | 4 | 1 | 1 | 1 | - | - | ||||||
| Prepaid Expense And Other Assets Current | 5 | 5 | 4 | 3 | 2 | 1 | 1 | 1 | 0 | ||||||
| Other Receivables Net Current | - | - | 0 | - | - | - | 0 | - | - | ||||||
| Other Assets Noncurrent | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finite Lived Intangible Assets Net | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 65 | 69 | 80 | 46 | 45 | 49 | 51 | 5 | 2 | ||||||
| Accounts Payable And Accrued Liabilities Current | 6 | 5 | 9 | 7 | 3 | 3 | 2 | 2 | 1 | ||||||
Liabilities Current | |||||||||||||||
| Contract With Customer Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | ||||||
| Liabilities Current | 6 | 5 | 9 | 7 | 3 | 3 | 3 | 3 | 2 | ||||||
| Other Liabilities Current | 0 | - | - | - | - | - | - | - | - | ||||||
| Convertible Debt Noncurrent | - | - | - | - | - | - | - | 1 | - | ||||||
| Deferred Income Tax Liabilities Net | - | - | - | - | - | 0 | - | - | - | ||||||
| Deferred Income Noncurrent | - | - | 0 | 0 | 0 | - | - | - | - | ||||||
| Derivative Liabilities Noncurrent | - | - | 5 | - | - | - | 6 | - | - | ||||||
| Contract With Customer Liability Noncurrent | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Warrants And Rights Outstanding | 5 | 4 | - | 5 | 10 | 5 | 6 | 2 | 1 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 12 | 12 | 17 | 12 | 13 | 8 | 12 | 8 | 3 | ||||||
| Common Stock Value | 134 | 134 | 134 | 102 | 99 | 99 | 99 | 49 | 49 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | |||||||||||||||
| Additional Paid In Capital | 31 | 27 | 26 | 22 | 22 | 20 | 17 | 19 | 18 | ||||||
| Stockholders Equity | 53 | 57 | 63 | 34 | 27 | 39 | 39 | -3 | -1 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -112 | -104 | -97 | -90 | -89 | -78 | -76 | -71 | -69 | ||||||
| Liabilities And Stockholders Equity | 65 | 69 | 80 | 46 | 45 | 49 | 51 | 5 | 2 | ||||||
| Preferred Class B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Issued | 22 | 22 | 22 | 16 | 16 | 16 | 16 | 6 | 6 | ||||||
| Shares Outstanding | 22 | 22 | 22 | 16 | 16 | 16 | 16 | 6 | 6 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAlpha Cognition Inc. (ACOG) — SEC Financial Statements & Analysis
Alpha Cognition Inc. (ACOG) is a biological products, (no diagnostic substances) company, incorporated in A1. Alpha Cognition Inc. trades on Nasdaq as: ACOG. Alpha Cognition Inc. (ACOG)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Alpha Cognition Inc. carries a market cap of $157.21M, a P/E ratio of -7.48x, a P/B ratio of 2.97x, a P/S ratio of 10.30x, an enterprise value of $115.77M, and an EV/EBITDA multiple of -4.37x. On profitability, it posts a gross margin of 95.76%, an operating margin of -174.70%, a net margin of -137.70%, a Return on Equity (ROE) of -52.75%, and a Return on Assets (ROA) of -38.33%. Per share, it reports EPS of $-0.97, diluted EPS of $-0.97, free cash flow per share of $-1.43, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 232.74% year-over-year, net income growth of -23.86% year-over-year, and EPS growth of -43.98% year-over-year. On the balance sheet, it maintains a current ratio of 9.03x, a quick ratio of 7.32x, working capital of $51.51M, a debt-to-equity ratio of 0.22x, a debt ratio of 0.18, an interest coverage ratio of -14.04x, free cash flow of $-31.18M (TTM), and net debt of $-41.44M. Figures sourced from SEC EDGAR.
- Market Cap
- $157.21M
- P/E TTM
- -7.48x
- EPS TTM
- $-0.97
- P/B TTM
- 2.97x
- ROE TTM
- -52.75%
- ROA TTM
- -38.33%
- Debt To Equity
- 0.22x
- Free Cash Flow TTM
- $-31.18M
- Net Revenue TTM Growth 1Y
- 232.74%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Alpha Cognition Inc. in?
Alpha Cognition Inc. (ACOG) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does ACOG trade on?
Alpha Cognition Inc. (ACOG) trades on the Nasdaq.
Where is Alpha Cognition Inc. incorporated?
Alpha Cognition Inc. is incorporated in British Columbia, Canada.
When was Alpha Cognition Inc. (ACOG)'s most recent SEC filing?
Alpha Cognition Inc. (ACOG)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is ACOG's market cap?
Alpha Cognition Inc. (ACOG) has a market capitalization of $157.21M as of 2026-06-30.
What is ACOG's EPS (earnings per share)?
Alpha Cognition Inc. (ACOG)'s trailing twelve month EPS is $-0.97 as of 2026-06-30.
What is ACOG's ROE (return on equity)?
Alpha Cognition Inc. (ACOG)'s trailing twelve month Return on Equity (ROE) is -52.75% as of 2026-06-30.
What is ACOG's ROA (return on assets)?
Alpha Cognition Inc. (ACOG)'s trailing twelve month Return on Assets (ROA) is -38.33% as of 2026-06-30.
What is ACOG's EV/EBITDA?
Alpha Cognition Inc. (ACOG)'s trailing twelve month EV/EBITDA is -4.37x as of 2026-06-30.